About us
Назад
About us
History
Structure
Management
Manufacturing
Назад
Manufacturing
API & FDF Experimental Producton
Сustom chemistry services
Preclinical research services
Biotechnological Producton (BioIntegrator)
Portfolio
Назад
Portfolio
BioIntegrator
Avifavir
Aviron
CardioSystemPharma
NewVac
Avineuro
Infrastructure
Назад
Infrastructure
ChemRar Research and Development Institute
Chemical Diversity Research Institute
API-Technology
Biotechnological production (BioIntegrator)
Technopark management
News
Contacts
RUS
ENG
+7 (495) 925-30-74
Home
>>
Gallery
>>
The launch meeting of the risk management Program the application of Nessler®
The launch meeting of the risk management Program the application of Nessler®
СМОТРЕТЬ
СМОТРЕТЬ
СМОТРЕТЬ
СМОТРЕТЬ
СМОТРЕТЬ
СМОТРЕТЬ
СМОТРЕТЬ
СМОТРЕТЬ
СМОТРЕТЬ
СМОТРЕТЬ
СМОТРЕТЬ
СМОТРЕТЬ
СМОТРЕТЬ
СМОТРЕТЬ
СМОТРЕТЬ
СМОТРЕТЬ
СМОТРЕТЬ
СМОТРЕТЬ
СМОТРЕТЬ
СМОТРЕТЬ
СМОТРЕТЬ
СМОТРЕТЬ
СМОТРЕТЬ
СМОТРЕТЬ
Company news
18.06.2025
The Russian innovative drug Aviandr® has been included in the international pharmaceutical register of the World Health Organization (WHO)
26.05.2025
CDRI Production Company (ChemRar Group) has successfully confirmed its compliance with GMP standards
19.05.2025
Andrey Ivashchenko, Head of the ChemRar Group, was awarded the title of «Honorary Worker of the Pharmaceutical Industry»
14.02.2025
Andrey Ivashchenko, Head of the Innovative Pharmaceuticals Committee of the National Champions Association, named the first signs of degradation in the pharmaceutical industry
28.12.2024
Against AIDS: If we don’t make the next generation of innovative drugs ourselves, in 5 years we will be treating our patients with Chinese drugs
All news
Ajax Call Form
Loading...
Close
Search for:
Search Button
×
